InsidersTradesSigma
동구바이오제약 Stock: price and insider trades · South Korea · DART (FSS)
Track the 동구바이오제약 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 동구바이오제약 has recorded 55 insider filings. Market capitalisation: €101.3bn. The latest transaction was disclosed on 7 July 2026 (Other). Among the most active insiders: 조용준. The full history is free.
55
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
14 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 3,680 of 26,212 companies
70.6
score / 100
Value69
Quality73
FCF yld-24%
Earn yld49%
EV/EBITDA3.1x
ROE·
Gross mgn60%
Net mgn21%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 July 2026
Declarations55 total
25 of 55 declarations
About 동구바이오제약
Donggu Bio Pharmaceutical is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and manufacturing of pharmaceutical products.